Chinese Poly(A) addition is considered to be an essential part of the process of mRNA biogenesis. It is currently believed that this sequence is generated in the nucleus by addition of adenylate residues to 3' OH termini on the nucleoplasmic RNA molecules. This is followed by specific fragmentation of these molecules, with the portion adjacent to the poly(A) retained as mRNA and transferred to the cytoplasm (1). According to this scheme, all the poly(A) present in cellular mRNA should be synthesized in the nucleus. It has been shown, however, that a poly(A) segment is also present in the mRNA of viruses that replicate in the cytoplasm (2-4). It has also been reported that polyadenylation of preexisting mRNA takes place in the cytoplasm of fertilized sea urchin eggs (5, 6).
Poly(A) addition is considered to be an essential part of the process of mRNA biogenesis. It is currently believed that this sequence is generated in the nucleus by addition of adenylate residues to 3' OH termini on the nucleoplasmic RNA molecules. This is followed by specific fragmentation of these molecules, with the portion adjacent to the poly(A) retained as mRNA and transferred to the cytoplasm (1) . According to this scheme, all the poly(A) present in cellular mRNA should be synthesized in the nucleus. It has been shown, however, that a poly(A) segment is also present in the mRNA of viruses that replicate in the cytoplasm (2) (3) (4) . It has also been reported that polyadenylation of preexisting mRNA takes place in the cytoplasm of fertilized sea urchin eggs (5, 6) .
The above instances of cytoplasmic polyadenylation suggest that the poly(A) segment may have an essential function in this cell compartment. This raises the possibility that poly(A) addition on cytoplasmic mRNA may be a normal feature of eukaryotic cells. We have obtained evidence for such a process in Chinese hamster and mouse sarcoma 180 cells treated with actinomycin to depress nuclear poly(A) synthesis. The time course of polyadenylation in the treated cells, as well as the characteristics of the labeled product, indicate that adenylate residues are added to the preexisting poly(A) segment on mRNA.
MATERIALS AND METHODS
Cell Incubation. Chinese hamster cells were grown in suspension culture (7) . For the incorporation experiments, logarithmically growing cells (cell density of 5 X 105/ml) 4091 were collected by centrifugation at room temperature and suspended in the culture medium at a concentration of 1 X 107 cells per ml. After a 30-min incubation, actinomycin D (5 jzg/ml) was added when required and the incubation was continued for an additional 30 min before addition of [2,8- sH]adenosine (15 Ci/mmol) to a level of 20 ACi/ml. Mouse sarcoma 180 ascites cells were incubated. as described (8) ,
with the same levels of labeled adenosine as for the Chinese hamster cells.
Preparation of Nuclear and Polysomal RNA. All cell samples were chilled rapidly and washed with either cold medium or 1% (w/v) NaCl. The cells were swollen in 10 mM Tris -HC (pH 7.6), 10 mM KC1, and 1 mM MgCl2, and disrupted with Triton X-100 (9) (for ascites cells) or by treatment with a Dounce homogenizer (for Chinese hamster cells). Crude nuclei were obtained by centrifugation at 800 X g and were purified by washing twice with Triton N-101 (10) . Polysomes were prepared from the 12,000 X g supernatant of homogenized cells by Mg precipitation (9) and washed twice with 30 mM MgC12. This procedure yields small ribonucleoprotein particles, in addition to single ribosomes and polysomes (11) . Nuclear RNA was prepared by a modification of the hot phenol extraction procedure designed to maximize the yield of poly(A) (12) . This procedure involves resuspending the nuclei in cold 10 mM Tris * HC (pH 7.6) and 2 mM EDTA, adding sodium dodecyl sulfate to a concentration of 0.5% (w/v), mixing the nuclei with an equal volume of cold aqueous phenol, and incubating the mixture at 550 for 5 min. Polysomal RNA was prepared by the pH 9 phenol extraction procedure (13) . The aqueous phases were extracted three times with fresh phenol before precipitation of the RNA.
Poly(A) was prepared by digestion with DNase and RNases A and T1, followed by adsorption on Millipore filters (9) . The material eluted from the filter was treated with phenol, the phenol was removed from the aqueous phase by extraction with ether, and the ether was removed by evapo-
ration. RESULTS
Effect of Actinomycin D on Poly(A) Synthesis. Actinomycin, when used at levels that block transcription in mammalian cells, causes a strong inhibition of poly(A) synthesis (14) . It has been shown that the extent of inhibition increases with the duration of the actinomycin treatment (15) . This pro- gressive effect has been attributed to gradual exhaustion of newly synthesized nucleoplasmic RNA molecules that serve as primers for poly(A) addition (9) . The extent of inhibition of poly(A) formation in Chinese hamster cells treated with actinomycin for 30 min before addition of labeled adenosine is shown in Tables 1 2, and 3. The residual poly(A) synthesis in these cells differs markedly from that of untreated cells, as judged by the differences in the time course of labeling with radioactive adenosine (Table 1 and Fig. 1 ). The labeling in the nucleus of normal cells is rapid and tends to level off within 1 hr after addition of the labeled precursor. Radioactive poly(A) accumulates in the cytoplasm at a linear rate, with no noticeable lag. This latter feature has been observed previously in mouse sarcoma 180 ascites cells (9) , and more recently in mouse L cells (16) . In the cells that were treated first with actinomycin, the initial incorporation into poly(A) is more rapid in the cytoplasm than in the nucleus. Poly(A) labeling levels off in the polysomes within 5-10 min, but Table 1 for details). Data from untreated cells and actinomycin-treated cells are from separated experiments, and the absolute levels of incorporation into poly(A) are not comparable. Cell suspensions were incubated in the presence or absence of actinomycin D for 30 min before addition of label. For cordycepin treatment, 50 ug/ml of drug was added 10 min before addition of label. Incubations with labeled adenosine were for 30 min. Data represent radioactivity in poly(A), determined as described in Table 1. continues in a more or less linear fashion in the nuclei. The pattern of inhibition of poly(A) synthesis by cordycepin is also altered in the actinomycin-treated cells. This drug, which markedly inhibits poly(A) formation (9, 14) , has relatively little effect on the residual synthesis in cells previously treated with actinomycin (Table 2 ).
An estimate of the magnitude of cytoplasmic poly(A) labeling in the actinomycin-treated cells was obtained by comparing the amounts of radioactivity in poly(A) after a 5-min incorporation period. Table 3 shows that the amount of radioactivity in the polysomal poly(A) of Chinese hamster cells pretreated with actinomycin is nearly as high as that of untreated cells. The effect of the drug treatment is more pronounced when longer periods of incorporation are used, since the radioactivity in poly(A) continues to rise linearly in the normal cells, but levels off rapidly in the cells pretreated with actinomycin (Fig. 1) . Thus, it appears that the initial rate of cytoplasmic poly(A) addition is similar to that of poly(A) transfer from nucleus to cytoplasm in normal cells.
Mouse sarcoma ascites cells responded to the actinomycin treatment in a manner similar to that of the Chinese hamster cells, but the inhibition of polysomal poly(A) labeling was more extensive (Table 3) .
Association of Labeled Poly(A) with Messenger RNA. Table  1 shows the distribution of labeled adenosine in polysomal RNA components. Most of the radioactivity in the mRNA of cells treated with actinomycin is in the poly(A) segment. Cell suspensions were incubated in the presence or absence of actinomycin for 30 min as in Table 1 , and incubations were continued in the presence of labeled adenosine for 5 min. Data represent radioactivity in poly(A), determined as described in Table 1 This is seen by comparing the amounts of radioactive material that bind to Millipore filters before and after digestion with RNase. The acid-insoluble radioactivity not associated with mRNA appears to represent mostly tRNA, as judged by its sedimentation behavior after deproteinization.
The bulk of labeled poly(A) in the cytoplasm of actinomycin-treated cells is associated with the polysomes. Little radioactive poly(A) was detected in a crude mitochondrial fraction prepared by differential centrifugation of disrupted cells. Moreover, ethidium bromide, an inhibitor of RNA synthesis in mitochondria (17) , had no effect on the actinomycin-resistant poly(A) synthesis. Zone centrifugation of the polysomal fraction showed that the poly(A) sediments with the polysomes (Fig. 2) . After deproteinization, the poly(A) remained associated with heterogeneous material that sediments like mRNA (Fig. 3) . It may be noted that the sedimentation profile in Fig. 3 shows a proportion of light RNA components greater than that which is usually observed in polysomal mRNA profiles of mammalian cells (8) . The latter, however, are obtained by measuring total radioactivity in the mRNA, a procedure that places greater emphasis on the larger RNA species. When polysomal mRNA labeled under normal conditions was assayed by measuring the radioactivity in the poly(A) segment only, a sedimentation profile similar to that shown in Fig. 3 was obtained.
Characteristics of the Poly(A) Segments Labeled in Actinomycin-treated Cells. Polyacrylamide gel electrophoresis of the polysomal poly(A) labeled in the presence of actinomycin shows that it has a heterogeneous distribution of sizes and an average mobility higher than that of normal newly synthesized poly(A) (Fig. 4) . These are characteristics of the poly(A) normally associated with the long-labeled mRNA (19, 20) . It appears, therefore, that the activity in the cytoplasm of the treated cells involves the extension of the poly(A) sequence in preexisting mRNA molecules. Such a process should produce poly(A) segments with a relatively small number of labeled adenylate residues at the 3' OH end. This hypothesis was verified by subjecting poly(A) preparations to alkaline hydrolysis and measuring the proportion of radioactivity Fig. 2 liberated as adenosine. Since the nucloside is generated from the 3' terminus, the ratio of radioactive AMP to adenosine should provide a measure of the size of the labeled poly(A) sequence (9) . While the polysomal poly(A) from normal cells yielded a ratio of 155, that from actinomycin-treated cells was only 6.5 (Table 4 ). The radioactive adenosine could not have arisen from short, fully labeled segments, since the poly(A) was first isolated by adsorption on Millipore filters, and short chains are not retained on the filters. This result indicates that the poly(A) isolated from the polysomes of actinomycintreated cells consists of long, unlabeled sequences terminated at the 3' end by 7-8 labeled nucleotides.
The distribution of sizes in the polysomal poly(A) preparation from normal cells labeled for 5 min suggests the occurrence of two populations (Fig. 4) . One is rather homogeneous, and apparently represents segments transferred from the nucleus. The other one is heterogeneous and resembles the population of segments labeled in the cells treated with actinomycin. This result provides an indication that cytoplasmic poly(A) chain extension also occurs in normal cells.
It can be detected only after short labeling periods, when relatively little newly formed poly(A)-containing RNA has reached the cytoplasm (Fig. 1) . Our data also indicate that the amounts of poly(A) sequences normally generated in the cytoplasm are the same as those produced in cells treated with actinomycin. The total amount of polysomal poly(A) labeling in the latter cells after a 5-min incorporation represents twothirds the corresponding value in normal cells ( Table 3 ). The proportion of the heterogeneous component in the electrophoretic profile of normal polysomal poly(A) is also about two-thirds (Fig. 4) . When the two profiles are superimposed, by use of relative scales adjusted to yield areas under the curves proportional to the respective amounts of total polysomal poly(A) labeling, the profile from actinomycin-treated cells coincides with that of the heterogeneous component from normal cells (see dotted line in Fig. 4) .
The electrophoretic pattern of nuclear poly(A) labeled in the presence of actinomycin shows a heterogeneous popu- lation of segments with an average mobility considerably lower than that of normal nuclear poly(A) (Fig. 4) . Endgroup analysis, on the other hand, indicates an average number of labeled residues of 39 ( Cell suspensions were incubated-in the presence or absence of actinomycin for 30 min as described in Table 1 and Materials and Methods.
['HIAdenosine was added and incubations were continued for 1 hr. Poly(A) preparations, obtained as described in
Materials and Methods, were subjected to alkaline hydrolysis followed by paper chromatography to separate adenosine from adenylic acid, as described (9) . Data represent radioactivity in nucleotide and nucleoside.
the size of the nuclear poly(A) segments has also been observed in mouse sarcoma ascites cells subjected to starvation (19) .
The drug cordycepin, which preferentially inhibits normal nuclear poly(A) synthesis, has relatively little effect on the cytoplasmic polyadenylation process. This may be a general characteristic of cytoplasmic poly(A) synthesis, since poly(A) addition both on mRNA in the cytoplasm of fertilized sea urchin eggs and on viral RNA in infected mammalian cells is unaffected by cordycepin (4, 6). The same is true, however, for nuclear poly(A) elongation in the Chinese hamster cells treated with actinomycin. This observation suggests that the effect of cordycepin on poly(A) synthesis is more complex than previously believed.
Since high levels of actinomycin were used in these studies in order to suppress de novo nuclear poly(A) synthesis, it is conceivable that the cytoplasmic labeling observed under these conditions might not be a reflection of normal cell metabolism. It is possible, however, to detect the cytoplasmic polyadenylation process in the untreated cells by using a short labeling period, when relatively little newly formed nuclear poly(A) has had time to reach the cytoplasm. Our data indicate that the rate of cytoplasmic polyadenylation is of the same order of magnitude as that of new poly(A) transfer from nucleus to cytoplasm.
The physiological significance of the cytoplasmic poly(A) 
